A carregar...
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Recently, two studies using ipilimumab, an anti-CTLA-4 monoclonal antibody (mab) demonstrated improvements in overall survival in the treatment of advanced melanoma. These studies utilized two different schedules of treatment in different patient categories (first and second line of treatment). Howe...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3262765/ https://ncbi.nlm.nih.gov/pubmed/22077981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-9-196 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|